Home | Articles
Published on:June 2017
Indian Journal of Pharmaceutical Education and Research, 2017; 51(2s):s129-s135
Original Article | doi:10.5530/ijper.51.2s.59

The impact of Clinical Pharmacist Lead Collaborative Care on Quality Of Life of the Patients with Bipolar Disorder: A Unicenter Prospective, Randomization Study


Authors and affiliation (s):

Parihar Ashish Singh1*, Ganachari Madiwalayya S2, Tekkalaki Bheemsain3, Wali Shashikala4

1Master of Pharmacy, Department of Pharmacy Practice, KLEU’s College of Pharmacy, Belagavi, Karnataka, INDIA.

2PhD, Department of Pharmacy Practice, KLEU’s College of Pharmacy, Belagavi, Karnataka, INDIA.

3M.D. in Psychiatry, Department of Psychiatry, Jawaharlal Nehru Medical College, Belagavi, Karnataka, INDIA.

4Master of Pharmacy, Department of Pharmacy Practice, KLEU’s College of Pharmacy, Belagavi, Karnataka, INDIA.

Abstract:

Background: Bipolar disorder is a chronic mental illness, characterized by the presence of manic, depressive and cyclic episodes, usually separated by asymptomatic intervals. Illness significantly affects the patients’ quality of life. Hence, clinical pharmacists can contribute to managing the disease condition of the patients, mainly with the use of effective and safe drugs, and improve the patient’s quality of life through pharmaceutical care. Methods/design: A Randomized, interventional, prospective study was performed on 304 patients, to compare and assess the impact of pharmaceutical care with the usual care. Patients with bipolar disorder, aged 18 to 65 years, who have been discharged from the outpatient department were randomized and enrolled in the study. The intervention group patients’ were served with pharmaceutical care, which was provided by clinical pharmacists, Psychiatrists and Nurses, on other hand control group patients were treated with the usual care. Quality of life of the patients was assessed at the baseline level to 3rd, 6th and 9th months of the follow-up. Result: Total 266 patients were completed the study. No statistically significant difference was observed at the demographic level and baseline level quality of life (p=0.547) in both the group. After the intervention in the interventional group, significant (p<0.001) improvement in the quality of life were observed during the study period. Conclusion: conducted study shows that, clinical pharmacist lead collaborative care can enhance the patients’ quality of life in compared to usual care, which is showing that, the participation of clinical pharmacist in psychiatry settings may lead to integration in health care delivery systems.

Key words: Quality Of Life, Bipolar Disorder, Pharmaceutical Care, Mania, Depression, Psycho-Education, Clinical Pharmacist.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the 2019 Release of Journal Citation Reports (source: 2018 Web of Science Data).

 

Impact Factor® as reported in the 2018 Journal Citation Reports® (Clarivate Analytics, 2019): 0.425

User login

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs